百济神州:Pharmacyclics诉讼所涉专利被裁定无效

中新经纬
Yesterday

中新经纬4月30日电 (王玉玲)30日早间,百济神州发布一则涉及诉讼的公告。该诉讼起源于2023年6月,美国生物制药公司艾伯维旗下的Pharmacyclics公司指控百济神州的药物泽布替尼侵犯专利。百济神州在30日公告中称,4月29日,USPTO(美国专利商标局)作出了一项最终书面决定,宣布Pharmacyclics在PGR程序(授权后复审)中受到百济神州质疑的‘803专利的全部权利无效。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10